<DOC>
	<DOCNO>NCT01946438</DOCNO>
	<brief_summary>The aim study describe safety immunogenicity Fluzone Quadrivalent Fluzone Intradermal vaccine adult 18 &lt; 65 year age , describe safety immunogenicity Fluzone Quadrivalent Fluzone High-Dose vaccine adult ≥ 65 year age . Primary Objective : - To describe safety 2013-2014 formulation Fluzone Quadrivalent Fluzone Intradermal vaccine adult 18 &lt; 65 year age safety 2013-2014 formulation Fluzone Quadrivalent Fluzone High-Dose vaccine adult ≥ 65 year age . Observational objective : - To describe immunogenicity 2013-2014 formulation Fluzone Quadrivalent Fluzone Intradermal vaccine adult 18 &lt; 65 year age immunogenicity 2013-2014 formulation Fluzone Quadrivalent Fluzone High-Dose vaccine adult ≥ 65 year age . - To evaluate compliance , term immunogenicity , study vaccine ( Fluzone Quadrivalent , Fluzone Intradermal , Fluzone High-Dose ) applicable age group historical requirement Committee Human Medicinal Products ( CHMP ) Note Guidance ( NfG ) CPMP/BWP/214/96 . - To submit serum select subject Center Biologics Evaluation Research ( CBER ) analysis World Health Organization ( WHO ) , Centers Disease Control Prevention ( CDC ) , Food Drug Administration ( FDA ) support formulation recommendation subsequent influenza vaccine .</brief_summary>
	<brief_title>Study Fluzone® Quadrivalent , Fluzone® Intradermal , Fluzone® High-Dose Influenza Virus Vaccines Adults</brief_title>
	<detailed_description>Participants 18 &lt; 65 year age enrollment randomize receive either Fluzone Quadrivalent Fluzone Intradermal vaccine . Participants ≥ 65 year age enrollment randomize receive either Fluzone Quadrivalent Fluzone High-Dose vaccine . Solicited adverse event ( AE ) information collect 7 day vaccination , unsolicited AE Serious adverse event information collect Visit 1 Visit 2 . Total duration participation study approximately 21 day .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Subject ≥ 18 year age day inclusion Informed consent form sign date Able attend schedule visit comply trial procedure . History serious adverse reaction influenza vaccine Receipt vaccine within 30 day receive study vaccine , plan receive another vaccine Visit 2 . Participation another interventional clinical trial investigate vaccine , drug , medical device , medical procedure 30 day precede first study vaccination course study , unless intervention study occur within 30 day prior first study vaccination none plan subject would complete safety surveillance present study Thrombocytopenia , may contraindication intramuscular vaccination , discretion Investigator Prior vaccination 20132014 formulation influenza vaccine Known systemic hypersensitivity egg , chicken protein , vaccine component , history lifethreatening reaction Fluzone Quadrivalent , Fluzone Intradermal , Fluzone HighDose vaccine vaccine contain substance ( complete list vaccine component include Prescribing Information ) Receipt immune globulin , blood , bloodderived product past 3 month Bleeding disorder receipt anticoagulants 3 week precede inclusion , may contraindication intramuscular vaccination , discretion Investigator Subject pregnant , lactating , childbearing potential ( consider nonchildbearing potential , female must premenarche postmenopausal least 1 year , surgically sterile , use effective method contraception abstinence least 4 week prior vaccination least 4 week vaccination ) Any condition opinion Investigator would pose health risk subject enrol could interfere evaluation vaccine Personal history GuillainBarré syndrome Known suspect congenital acquired immunodeficiency ; receipt immunosuppressive therapy , anticancer chemotherapy radiation therapy , within precede 6 month ; longterm systemic corticosteroid therapy ( prednisone equivalent 2 consecutive week within past 3 month ) Chronic illness , opinion Investigator , stage might interfere trial conduct completion Seropositivity human immunodeficiency virus ( HIV ) , hepatitis B , hepatitis C , report subject Deprived freedom administrative court order , emergency setting , hospitalize involuntarily Current alcohol drug addiction , opinion Investigator , might interfere ability comply trial procedure Moderate severe acute illness/infection ( accord Investigator judgment ) febrile illness ( temperature ≥ 100.4°F ] ) day vaccination . A prospective subject include study condition resolve febrile event subside Identified Investigator employee Investigator study center direct involvement propose study , identify immediate family member ( i.e. , parent , spouse , natural adopt child ) Investigator employee direct involvement propose study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Fluzone® Quadrivalent , Influenza Virus Vaccine ( 2013-2014 formulation ) ,</keyword>
	<keyword>Fluzone® Intradermal , Influenza Virus Vaccine ( 2013-2014 formulation ) ,</keyword>
	<keyword>Fluzone® High-Dose , Influenza Virus Vaccine ( 2013-2014 formulation )</keyword>
</DOC>